Kien-Thiam Tan

8PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai

|Apr 12, 2022
Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1.

Ting-Ting Liu, Chien-Feng Li, Kien-Thiam Tan

|Dec 13, 2021
Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.

Nai-Wen Kang, Kien-Thiam Tan, Chien-Feng Li

|May 05, 2021
Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations.

Chiao-En Wu, Ca Tung Ng, Kien Thiam Tan

|Mar 20, 2020
Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab.

Chi-Wei Tao, Mei-Yin Chen, Ching-Min Tseng

|Dec 03, 2019
Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group.

Chyong Huey Lai, Elizabeth Vallikad, Hao Lin

Pageof 2

Frequent Collaborators

2 joint publications

Nina Lapke

1 joint publications

Hung-Chih Hsu

1 joint publications

Wen-Sy Tsai

1 joint publications

Chyong Huey Lai